ProPhase Labs (NASDAQ:PRPH – Get Rating) was downgraded by equities researchers at TheStreet from a “b-” rating to a “c+” rating in a note issued to investors on Tuesday, TheStreetRatingsTable reports.
Several other brokerages have also weighed in on PRPH. HC Wainwright cut their target price on ProPhase Labs from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Monday. Zacks Investment Research raised ProPhase Labs from a “hold” rating to a “buy” rating and set a $7.75 price objective on the stock in a report on Tuesday, February 22nd. Finally, StockNews.com began coverage on ProPhase Labs in a research note on Friday, May 13th. They set a “sell” rating on the stock. One analyst has rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $10.88.
NASDAQ:PRPH opened at $7.67 on Tuesday. The stock’s fifty day moving average is $7.31 and its two-hundred day moving average is $6.95. ProPhase Labs has a 52 week low of $4.44 and a 52 week high of $8.58. The company has a quick ratio of 3.65, a current ratio of 3.67 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $118.81 million and a P/E ratio of 7.59.
ProPhase Labs Company Profile (Get Rating)
ProPhase Labs, Inc engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.
- Get a free copy of the StockNews.com research report on ProPhase Labs (PRPH)
- MarketBeat Podcast: Options Trading As Easy As Trading Stocks
- The TJX Companies: It’s Not All Doom And Gloom In Retail
- Simply Good Foods Stock is Simply Looking Good Down Here
- Shoe Carnival’s Q1 Results Are No Joke, Shares Fall 15%
- Analog Devices Is Ready To Scale New Highs Despite Tech Wreck
Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.